KMT2D and breast cancer: Sangster et al. studied mutations in MIBC which is characterized by an abundance of mutations especially in chromatin modification and DNA damage response genes and reported two mutually exclusive mutation patterns in KDM6A and KMT2D as well as KDM6A and RB1, pointing to possible mutational interactions in BC (Sangster et al. 2022).